Table 3 Burn-specific assessment and intervention. Data are expressed as numbers and frequencies for categorical variables and medians and interquartile ranges (25th to 75th percentile). [] = missing values
Study group n = 86 (100%) | TBSA < 20% n = 55 (64%) | TBSA ≥20% n = 31 (36%) | p-value | |
|---|---|---|---|---|
Prehospital (initial) TBSA estimation (in %) [5] | 10 (6–25) | 9 (5–10) | 40 (25–50) | < 0.001* |
Hospital (final) TBSA measurement (in %) [1] | 10 (6–27) | 8.5 (4–10) | 43 (25–55) | < 0.001* |
Absolute variation of TBSA [5] | 0 (0–3) | 0 (0–2) | 0 (0–4) | 0.2093 |
Crystalloid infusion (ml/kg/TBSA) [33] | 0.8 (0.3–1.4) | 1.3 (0.8–1.8) | 0.3 (0.1–0.4) | < 0.001* |
Crystalloid infusion reported to 8 h (ml/kg/TBSA) [34] | 10.5 (3.4–17.4) | 15.5 (12–25) | 2.7 (1.4–4) | < 0.001* |
Initial pain score (VNRS) [27] | 6 (3–8) | 5.5 (3–7) | 8 (4–10) | 0.039* |
Pain score at ED arrival (VNRS) [51] | 3 (2–5) | 3 (2–5) | 4 (3–7) | 0.154 |
Analgesia provision, n (%) [0] | 61 (71) | 37 (67) | 24 (77) | 0.32 |
Intranasal medication, n (%) [0] | 9 (10) | 8 (15) | 1 (3.2) | 0.1 |
Fentanyl administration, n (%) [0] | 59 (69) | 37 (67) | 22 (71) | 0.723 |
Fentanyl dose (mcg/kg) [0] | 1.7 (1–2.6) | 1.4 (1–1.9) | 2.7 (1.7–4.7) | 0.002* |
Ketamine administration, n (%) [0] | 7 (8.1) | 1 (1.8) | 6 (19) | 0.004* |
Ketamine dose (mg/kg) [0] | 2.1 (0.3–3.2) | 2.1 | 2.4 (0.3–3.2) | 1 |